nocodazole has been researched along with Cancer of Esophagus in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Esophageal cancer is a common malignancy with a high mortality rate." | 1.39 | Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells. ( Cai, Y; Hu, M; Jiang, F; Liu, C; Liu, Q; Luo, J; Luo, M; Shi, Q; Song, P; Tang, M; Weng, Y; Yang, D; Zhan, X; Zhang, F; Zhang, Y; Zhou, L; Zuo, G, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, M | 1 |
Liu, Q | 1 |
Song, P | 1 |
Zhan, X | 1 |
Luo, M | 1 |
Liu, C | 1 |
Yang, D | 1 |
Cai, Y | 1 |
Zhang, F | 1 |
Jiang, F | 1 |
Zhang, Y | 1 |
Tang, M | 1 |
Zuo, G | 1 |
Zhou, L | 1 |
Luo, J | 1 |
Shi, Q | 1 |
Weng, Y | 1 |
1 other study available for nocodazole and Cancer of Esophagus
Article | Year |
---|---|
Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Prolifer | 2013 |